Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cohbar Inc (NQ: CWBR )

1.220 USD -0.070 (-5.43%)
Streaming Delayed Price Updated: 2:20 PM EDT, Apr 13, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 395,693
Open 1.280
Bid (Size) 1.210 (221)
Ask (Size) 1.220 (8)
Prev. Close 1.290
Today's Range 1.180 - 1.305
52wk Range 0.8500 - 4.250
Shares Outstanding 42,363,670
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
CohBar Reports Fourth Quarter 2020 Financial Results and Provides Business Update
Company to host conference call and webcast at 5:00 p.m. ET 
From GlobeNewswire News Releases
CohBar Completes Enrollment in the Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity
From GlobeNewswire News Releases

Performance

YTD
-7.58%
-7.58%
1 Month
-24.23%
-24.23%
3 Month
-14.69%
-14.69%
6 Month
+22.25%
+22.25%
1 Year
+0.82%
+0.82%

More News

Read More
CohBar to Announce 2020 Fourth Quarter Financial Results and Provide Business Update on March 30, 2021
From GlobeNewswire News Releases
CohBar Nominates CB5138 Analog as Lead Clinical Candidate for Idiopathic Pulmonary Fibrosis and other Fibrotic Diseases
From GlobeNewswire News Releases
Best Stocks To Buy Today? 4 Biotech Stocks To Know
Tags Market News
From StockMarket.com
CohBar to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
From GlobeNewswire News Releases
CohBar to Present at the 33rd Annual ROTH Conference
From GlobeNewswire News Releases
CohBar to Present at the H.C. Wainwright Global Life Sciences Conference
From GlobeNewswire News Releases
CohBar to Present at the BIO CEO & Investor Digital Conference
From GlobeNewswire News Releases
CohBar to Present at the 3rd Annual Longevity Therapeutics Conference
From GlobeNewswire News Releases
CohBar Announces Preclinical Collaboration with NIAID to Evaluate Potential of CB5064 Analogs for Treatment of COVID-19 ARDS
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.